Position in PTCT
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$1,354,083
-$581,529 QoQ
Shares Held
19,875
-22.0% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Phocas Financial Corp. holds $6,718,190 across 5 Biotechnology names. PTCT ranks #3 (20.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACAD |
Acadia Pharmaceuticals Inc
|
81,347 | $1,810,784 | |
| 2 | ZVRA |
Zevra Therapeutics, Inc.
|
159,423 | $1,485,822 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
This page
|
19,875 | $1,354,083 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
50,299 | $1,185,044 | |
| 5 | ADMA |
Adma Biologics, Inc.
|
97,942 | $882,457 |
All Filings in PTCT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,354,083 | 19,875 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,935,612 | 25,482 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,285,050 | 37,234 | Shares | Sole | 2025-11-12 | |
| 2023-09-30 | $1,449,949 | 64,701 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $3,281,946 | 80,697 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $4,936,036 | 101,900 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $2,666,747 | 69,865 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $3,510,787 | 69,936 | Shares | Sole | 2022-10-14 | |
| No filing history on record for this holder in this stock. | ||||||